BlackRock’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $7.3M | Sell |
|
|||||
|
2024
Q4 | $6.69M | Buy |
|
|||||
|
2024
Q3 | $6.41M | Buy |
|
|||||
|
2024
Q2 | $7.08M | Buy |
|
|||||
|
2024
Q1 | $196K | Buy |
|
|||||
|
2023
Q4 | $733 | Sell |
|
|||||
|
2023
Q3 | $847 | Hold |
|
|||||
|
2023
Q2 | $908 | Hold |
|
|||||
|
2023
Q1 | $524 | Sell |
|
|||||
|
2022
Q4 | $61.2K | Sell |
|
|||||
|
2022
Q3 | $78K | Buy |
|
|||||
|
2022
Q2 | $45K | Buy |
|
|||||
|
2022
Q1 | $2K | Hold |
|
|||||
|
2021
Q4 | $2K | Buy |
|
|||||
|
2021
Q3 | $2K | Hold |
|
|||||
|
2021
Q2 | $2K | Hold |
|
|||||
|
2021
Q1 | $4K | Sell |
|
|||||
|
2020
Q4 | $68K | Sell |
|
|||||
|
2020
Q3 | $34K | Hold |
|
|||||
|
2020
Q2 | $44K | Buy |
|
|||||
|
2020
Q1 | $23K | Hold |
|
|||||
|
2019
Q4 | $43K | Hold |
|
|||||
|
2019
Q3 | $35K | Hold |
|
|||||
|
2019
Q2 | $61K | Hold |
|
|||||
|
2019
Q1 | $50K | Hold |
|
|||||
|
2018
Q4 | $45K | Hold |
|
|||||
|
2018
Q3 | $116K | Buy |
|
|||||
|
2018
Q2 | $386K | Sell |
|
|||||
|
2018
Q1 | $560K | Sell |
|
|||||
|
2017
Q4 | $852K | Buy |
|
|||||
|
2017
Q3 | $1.01M | Buy |
|
|||||
|
2017
Q2 | $522K | Sell |
|
|||||
|
2017
Q1 | $3.51M | Buy |
|
|||||
|
2016
Q4 | $6K | Sell |
|
|||||
|
2016
Q3 | $10K | Hold |
|
|||||
|
2016
Q2 | $9K | Buy |
|
|||||
|
2016
Q1 | $14K | Sell |
|
|||||
|
2015
Q4 | $33K | Buy |
|
|||||
|
2015
Q3 | $2K | Hold |
|
|||||
|
2015
Q2 | $4K | Hold |
|
|||||
|
2015
Q1 | $6K | Hold |
|
|||||
|
2014
Q4 | $5K | Buy |
|